» Articles » PMID: 38028609

Comparative Analyses of Salivary Exosomal MiRNAs for Patients with or Without Lung Cancer

Overview
Journal Front Genet
Date 2023 Nov 29
PMID 38028609
Authors
Affiliations
Soon will be listed here.
Abstract

Lung cancer is the most frequent cause of cancer-related deaths worldwide. Exosomes are involved in different types of cancer, including lung cancer. We collected saliva from patients with (LC) or without (NC) lung cancer and successfully isolated salivary exosomes by ultracentrifugation. MiRNA sequencing was implemented for the exosome samples from NC and LC groups, dgeR was used to determine differentially expressed miRNAs (DE miRNAs), and quantitative real-time polymerase chain reaction (qPCR) was used to verify three differentially expressed microRNAs (miRNAs). A total of 372 miRNAs were identified based on the sequencing results. Subsequently, 15 DE miRNAs were identified in LC vs. NC, including eight upregulated miRNAs and seven downregulated miRNAs. Some DE miRNAs were validated via qPCR. A total of 488 putative target genes of the upregulated DE miRNAs were found, and the functional analyses indicated that numerous target genes were enriched in the pathways associated with cancer. This suggests that miRNAs of salivary exosomes might have the potential to be used as biomarkers for prediction and diagnosis of lung cancer.

Citing Articles

Dynamic and functional analyses of exosomal miRNAs regulating cellular microenvironment of ovarian cancer cells.

Wang Z, Huang Y, He S, Zhou Y, Zhao L, Wang F J Ovarian Res. 2025; 18(1):25.

PMID: 39930447 PMC: 11808964. DOI: 10.1186/s13048-025-01608-3.


Nanoscale Extracellular Vesicle-Enabled Liquid Biopsy: Advances and Challenges for Lung Cancer Detection.

Khan A, Raza F, He N Micromachines (Basel). 2024; 15(10).

PMID: 39459055 PMC: 11509190. DOI: 10.3390/mi15101181.


Saliva, a molecular reflection of the human body? Implications for diagnosis and treatment.

Geli V, Nabet N Cell Stress. 2024; 8:59-68.

PMID: 38826491 PMC: 11144459. DOI: 10.15698/cst2024.05.297.


New frontiers in salivary extracellular vesicles: transforming diagnostics, monitoring, and therapeutics in oral and systemic diseases.

Cui L, Zheng J, Lu Y, Lin P, Lin Y, Zheng Y J Nanobiotechnology. 2024; 22(1):171.

PMID: 38610017 PMC: 11015696. DOI: 10.1186/s12951-024-02443-2.


Salivary metabolomic biomarkers for non-invasive lung cancer detection.

Kajiwara N, Kakihana M, Maeda J, Kaneko M, Ota S, Enomoto A Cancer Sci. 2024; 115(5):1695-1705.

PMID: 38417449 PMC: 11093188. DOI: 10.1111/cas.16112.

References
1.
Krek A, Grun D, Poy M, Wolf R, Rosenberg L, Epstein E . Combinatorial microRNA target predictions. Nat Genet. 2005; 37(5):495-500. DOI: 10.1038/ng1536. View

2.
Bai S, Wei Y, Liu R, Xu R, Xiang L, Du J . Role of tumour-derived exosomes in metastasis. Biomed Pharmacother. 2022; 147:112657. DOI: 10.1016/j.biopha.2022.112657. View

3.
Huang D, Sherman B, Lempicki R . Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009; 4(1):44-57. DOI: 10.1038/nprot.2008.211. View

4.
Sun Y, Huo C, Qiao Z, Shang Z, Uzzaman A, Liu S . Comparative Proteomic Analysis of Exosomes and Microvesicles in Human Saliva for Lung Cancer. J Proteome Res. 2018; 17(3):1101-1107. DOI: 10.1021/acs.jproteome.7b00770. View

5.
Shan S, Lin X, Li F, Xu F, Zhong J, Guo B . Exosomes and Bone Disease. Curr Pharm Des. 2019; 25(42):4536-4549. DOI: 10.2174/1381612825666191127114054. View